104 Results for "

Glycosmis angustifolia Lindl. ex Wight & Arn.

" in MedChemExpress (MCE) Product Catalog:
Products (104)

104 Results for "Glycosmis angustifolia Lindl. ex Wight & Arn." in MCE Product Catalog:

15
15 Publications Verification
Art. -Nr.: HY-16060
CAS. Nr.: 956104-40-8
Synonyms: ARN-509
Target:  

Androgen Receptor

Forschungsgebiete:  

Cancer

Apalutamide (ARN-509) is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM .
9
9 Cited Publications
Art. -Nr.: HY-18204A
CAS. Nr.: 936623-90-4
Synonyms: LCZ696
Sacubitril/Valsartan (LCZ696), comprised Valsartan and Sacubitril (AHU377) in 1:1 molar ratio, is a first-in-class, orally bioavailable, and dual-acting angiotensin receptor-neprilysin (ARN) inhibitor for hypertension and heart failure . Sacubitril/Valsartan ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis .
6
6 Cited Publications
Art. -Nr.: HY-N0365
CAS. Nr.: 81-27-6
Sennoside A is an anthraquinone glycoside found in senna (Cassia angustifolia). Sennoside A is an HIV-1 inhibitor (IC50=3.8 μM) that inhibits HIV-1 replication. Sennoside A also inhibits HIV-1 reverse transcriptase (RT)-related DNA polymerase (RDDP) and ribonuclease H (Ribonuclease H) with IC50s of 1.9 μM and 5.3 μM, respectively .
6
6 Cited Publications
Art. -Nr.: HY-12864
CAS. Nr.: 1365888-06-7
Reinheit:  99.85%
Synonyms: ARN-810; GDC-0810
Target:  

Estrogen Receptor/ERR

Forschungsgebiete:  

Cancer

Brilanestrant (ARN-810; GDC-0810) is an orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM.
6
6 Cited Publications
Art. -Nr.: HY-N0365R
CAS. Nr.: 81-27-6
Sennoside A (Standard) is the analytical standard of Sennoside A. This product is intended for research and analytical applications. Sennoside A is an anthraquinone glycoside, found in Senna (Cassia angustifolia) . Sennoside A is a HIV-1 inhibitor effective on HIV-1 replication .
4
4 Cited Publications
Art. -Nr.: HY-120856
CAS. Nr.: 1613710-01-2
Reinheit:  99.66%
Forschungsgebiete:  

Inflammation/Immunology Cancer

ARN-3236 is an oral active and selective inhibitor of salt-inducible kinase 2 (SIK2), with IC50s of <1 nM, 21.63 nM and 6.63 nM for SIK2, SIK1 and SIK3, respectively. Has anti-cancer activity .
3
3 Cited Publications
Art. -Nr.: HY-N0778
CAS. Nr.: 55033-90-4
Isorhamnetin-3-O-neohespeidoside is a flavonoid. Isorhamnetin-3-O-neohespeidoside can be isolated from Typha angustifolia. Isorhamnetin-3-O-neohespeidoside inhibits xanthine oxidase activity with an IC50 of 48.75 μg mL. Isorhamnetin-3-O-neohespeidoside has antioxidant and osteoclastogenic activities. Isorhamnetin-3-O-neohespeidoside can be used in research of bone .
1
1 Cited Publications
Art. -Nr.: HY-117419A
CAS. Nr.: 25905-14-0
Reinheit:  ≥98.0%
(±)-Lavandulyl acetate can be isolated from the oil components of Lavandula angustifolia Mill .
1
1 Cited Publications
Art. -Nr.: HY-103691A
CAS. Nr.: 1700693-96-4
Reinheit:  99.54%
Target:  

Autophagy Apoptosis

Forschungsgebiete:  

Cancer

ARN5187 trihydrochloride is a lysosomotropic REV-ERBβ ligand with a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy. ARN5187 trihydrochloride shows lysosomotropic potency and cytotoxicity. ARN5187 trihydrochloride induces apoptosis .
Art. -Nr.: HY-145339
CAS. Nr.: 1971937-18-4
Reinheit:  99.80%
Target:  

Ceramidase

ARN19702 is a selective, orally active, reversible, and brain-penetrant N-acylethanolamine acid amidase (NAAA) inhibitor with an IC50 of 230 nM for human NAAA. ARN19702 has pain relief effects .
Art. -Nr.: HY-103592
CAS. Nr.: 1644158-57-5
Reinheit:  99.29%
Target:  

Ceramidase

Forschungsgebiete:  

Cancer

ARN14974, a benzoxazolone carboxamide, is a potent and systemically active inhibitors of intracellular acid ceramidase (IC50=79 nM) .
Art. -Nr.: HY-N5037
CAS. Nr.: 109008-27-7
Ilexoside D is isolated from the roots of Ilex pubescens Hook. et Arn. Ilexoside D has the anti-tissue factor activity as well as the antithrombotic activity .
Art. -Nr.: HY-137466
CAS. Nr.: 2230854-93-8
Reinheit:  98.08%
Target:  

Topoisomerase

Forschungsgebiete:  

Cancer

ARN-21934 is a potent, highly selective, blood-brain barrier (BBB) penetrant inhibitor for human topoisomerase II α over β. ARN-21934 inhibits DNA relaxation with an IC50 of 2 μM as compared to the anticancer agent Etoposide (IC50=120 μM). ARN-21934 exhibits a favorable in vivo pharmacokinetic profile and is a promising lead compound for anticancer research .
Art. -Nr.: HY-115498
CAS. Nr.: 1037837-27-6
Reinheit:  99.08%
ARN14494 is a potent and selective serine palmitoyltransferase (SPT) inhibitor, with an IC50 of 27.3 nM. ARN14494 affects the CNS in terms of anti-inflammation and neuroprotection. ARN14494 protects neurons from β-amyloid 1-42-induced neurotoxicity through a variety of mechanisms, including anti-oxidation, anti-apoptosis, and anti-inflammation. ARN14494 can be used for Alzheimer’s disease research .
Art. -Nr.: HY-120813
CAS. Nr.: 1373625-34-3
Reinheit:  98.83%
Synonyms: URB913
Target:  

Ceramidase

Forschungsgebiete:  

Inflammation/Immunology

ARN 077 is a potent and selective N-acylethanolamine acid amidase (NAAA) inhibitor with an IC50 of 7 nM for human NAAA . ARN 077 significantly increases palmitoyl ethanolamine (PEA) levels within the CNS and has broad antinociceptive activity in mice and rats .
Art. -Nr.: HY-18292
CAS. Nr.: 102212-26-0
Target:  

Amyloid-β

Forschungsgebiete:  

Neurological Disease

ARN2966 is a potent, orally active and cross the blood-brain barrier amyloid precursor protein (APP) translation modulator.
Art. -Nr.: HY-144290
CAS. Nr.: 2649882-80-2
Reinheit:  99.66%
Target:  

GSK-3 DYRK

Forschungsgebiete:  

Neurological Disease

ARN25068 is a sub-micromolar inhibitor of the three protein kinases, GSK-3β, FYN and DYRK1A to tackle tau hyperphosphorylation .
Art. -Nr.: HY-N1973
CAS. Nr.: 37271-17-3
Sennoside D is an anthraquinone glycoside, found in leaves and pods of Senna (Cassia angustifolia) .
Art. -Nr.: HY-N6935
CAS. Nr.: 517-44-2
Sennidin B, a stereoisomer isolated from the leaves of Cassia angustifolia, has lower activity than Sennidin A. Sennidin A inhibits HCV NS3 helicase, with an IC50 of 0.8 μM. Sennidin A induces phosphorylation of Akt and glucose transporter 4 (GLUT4) translocation. Sennidin A stimulates the glucose incorporation .
Art. -Nr.: HY-163171
CAS. Nr.: 1214569-31-9
Target:  

Chloride Channel

Forschungsgebiete:  

Neurological Disease

ARN 11391 is a selective enhancer of inositol triphosphate receptor type 1 (ITPR1). ARN 11391 can be used in the study of spinocerebellar ataxia .